{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T15:30:47Z","timestamp":1782055847753,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jpba.2021.114222","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T19:19:41Z","timestamp":1624562381000},"page":"114222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Characterization of the metabolites of irisflorentin by using ultra-high performance liquid chromatography combined with quadrupole\/orbitrap tandem mass spectrometry"],"prefix":"10.1016","volume":"203","author":[{"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Xing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.114222_bib0005","volume":"Vol. 1","author":"Chinese Pharmacopoeia Committee","year":"2020"},{"key":"10.1016\/j.jpba.2021.114222_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2016.03.046","article-title":"Belamcanda chinensis (L.) DC-An ethnopharmacological, phytochemical and pharmacological review","volume":"186","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2021.114222_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/np980271b","article-title":"Iridal-type triterpenoids with ichthyotoxic activity from Belamcanda chinensis","volume":"62","author":"Ito","year":"1999","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2021.114222_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11418-007-0147-6","article-title":"New isoflavones from Belamcandae Rhizoma","volume":"61","author":"Moriyasu","year":"2007","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.jpba.2021.114222_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jpba.2011.05.040","article-title":"Characterization and determination of the major constituents in Belamcandae rhizoma by HPLCDAD-ESI-MSn","volume":"56","author":"Zhang","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114222_bib0030","first-page":"213","article-title":"Antimutagenic and antioxidant activity of the extract from Belamcanda chinensis (L.) DC","volume":"63","author":"Wozniak","year":"2006","journal-title":"Acta Pol.Pharm."},{"key":"10.1016\/j.jpba.2021.114222_bib0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1271\/bbb.65.939","article-title":"Detection of antifungal activity in Belamcanda chinensis by a single-cell bioassay method and isolation of its active compound, tectorigenin","volume":"65","author":"Oh","year":"2001","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.jpba.2021.114222_bib0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3727\/096368915X687002","article-title":"Irisflorentin modifies properties of mouse bone marrow-derived dendritic cells and reduces the allergic contact hypersensitivity responses","volume":"24","author":"Fu","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.jpba.2021.114222_bib0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7603\/s40681-015-0004-y","article-title":"Irisflorentin improves \u03b1-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson\u2019s disease therapy","volume":"5","author":"Chen","year":"2015","journal-title":"Biomedicine (Taipei)"},{"key":"10.1016\/j.jpba.2021.114222_bib0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/17425255.2017.1351944","article-title":"Metabolite profiling in early clinical drug development: current status and future prospects","volume":"13","author":"Ufer","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2021.114222_bib0055","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/bmc.3692","article-title":"Characterization of in vitro metabolites of irisflorentin by rat liver microsomes using high performance liquid chromatography coupled with tandem mass spectrometry","volume":"9","author":"Jia","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2021.114222_bib0060","first-page":"465","article-title":"Integrated P450 reaction phenotyping: Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes","volume":"57","author":"Rodrigues","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2021.114222_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/03602532.2011.605791","article-title":"Metabolic activation in drug-induced liver injury","volume":"44","author":"Kalgutkar","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jpba.2021.114222_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A comprehensive listing of bioactivation pathways of organic functional groups","volume":"6","author":"Kalgutkar","year":"2005","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2021.114222_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/17425250802665706","article-title":"Analytical strategies for the screening and evaluation of chemically reactive drug metabolites","volume":"5","author":"Wen","year":"2009","journal-title":"Expert. Opin. Drug Metab. Toxcol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:17:04Z","timestamp":1760001424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"alternative-id":["S0731708521003332"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114222","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the metabolites of irisflorentin by using ultra-high performance liquid chromatography combined with quadrupole\/orbitrap tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114222"}}